Kura Oncology Inc (KURA)

Nov 23, 2024

Kura Oncology partners Kyowa Kirin to advance AML treatment - MSN

Nov 23, 2024

Nov 23, 2024

Kura Crashes 37% After $1.53 Billion Deal Slams The Door On A Takeover - MSN

Nov 23, 2024

Nov 23, 2024

Kura Oncology (NASDAQ:KURA) Sees Strong Trading Volume on Analyst Upgrade - MarketBeat

Nov 23, 2024

Nov 23, 2024

Kura Oncology, Inc. (KURA): Among the Most Promising Cancer Stocks According to Hedge Funds - Insider Monkey

Nov 23, 2024

Nov 22, 2024

Stifel cuts Kura Oncology target to $11 from $18, holds rating - Investing.com Canada

Nov 22, 2024

Nov 22, 2024

Firm Advises Kura Oncology on Global Strategic Collaboration with Kyowa Kirin - Wilson Sonsini

Nov 22, 2024

Nov 22, 2024

10 Most Promising Cancer Stocks According to Hedge Funds - Insider Monkey

Nov 22, 2024

Nov 22, 2024

Kura Oncology Stock Slips Following Collaboration With Kyowa: Retail Turns Extremely Bullish - MSN

Nov 22, 2024

Nov 22, 2024

Bank of America Has Lowered Expectations for Kura Oncology (NASDAQ:KURA) Stock Price - MarketBeat

Nov 22, 2024

Nov 21, 2024

Earnings call: Kura Oncology reports on ziptamenib's progress in Q3 - Investing.com India

Nov 21, 2024

Nov 21, 2024

Kura Oncology inks global deal with Kyowa Kirin By Investing.com - Investing.com Nigeria

Nov 21, 2024

Nov 21, 2024

Kura, Kyowa Kirin to co-develop ziftomenib in $1.49B deal - BioWorld Online

Nov 21, 2024

Nov 21, 2024

Kura Oncology Gets $330M to Kick Off Global Leukemia Drug Pact With Kyowa Kirin - MedCity News

Nov 21, 2024

Nov 21, 2024

Stock market news: Perspective Therapeutics -44.33%, Pyxis Oncology -42.93% among top losers during mid day trading - Business Upturn

Nov 21, 2024

Nov 21, 2024

Kura Oncology: A Contender In The Field Of Precision Medicine - Seeking Alpha

Nov 21, 2024

Nov 21, 2024

Kura Oncology shares hold Buy rating after Kyowa Kirin deal By Investing.com - Investing.com Canada

Nov 21, 2024

Nov 21, 2024

Stock market today: Pyxis Oncology plunges by 47.25% while Perspective Therapeutics declines by 46.68% in early trading - Business Upturn

Nov 21, 2024

Nov 21, 2024

Stock market today: SCWorx Corp. gains 141.81% while Pyxis Oncology down by 46.41% in early trading - Business Upturn

Nov 21, 2024

Nov 21, 2024

Kura Oncology tumbles as Kyowa collaboration seen hitting M&A prospects By Investing.com - Investing.com Canada

Nov 21, 2024

Nov 21, 2024

Buy rating reiterated for Kura Oncology stock, analyst raises target on ziftomenib advancements - Investing.com Canada

Nov 21, 2024

Nov 21, 2024

Biotech Collapses 27% After Slamming The Door On A Takeover - Investor's Business Daily

Nov 21, 2024

Nov 21, 2024

HC Wainwright Forecasts Strong Price Appreciation for Kura Oncology (NASDAQ:KURA) Stock - MarketBeat

Nov 21, 2024

Nov 21, 2024

Kura Signs Leukemia Pact with Kyowa Kirin After Losing Race to Syndax - BioSpace

Nov 21, 2024

Nov 21, 2024

Kura Oncology inks global deal with Kyowa Kirin - Investing.com

Nov 21, 2024

Nov 21, 2024

Kura and Kyowa Kirin sign ziftomenib deal - The Pharma Letter

Nov 21, 2024

Nov 21, 2024

Kura partners with Kyowa Kirin to advance AML treatment - Pharmaceutical Technology

Nov 21, 2024

Nov 21, 2024

Kura Oncology and Kyowa Kirin Announce Global Strategic Collaboration to Develop and Commercialize Ziftomenib in Acute Leukemias - Barchart

Nov 21, 2024

Nov 21, 2024

Earnings call: Kura Oncology reports on ziptamenib's progress in Q3 By Investing.com - Investing.com UK

Nov 21, 2024

Nov 20, 2024

Kura stock slides 17% on Kyowa Kirin deal for ziftomenib - MSN

Nov 20, 2024

Nov 20, 2024

Kura Oncology Shares Fall 14% on Plans for Cancer-Drug Collaboration - MarketWatch

Nov 20, 2024

Nov 20, 2024

KURAKura Oncology, Inc. Latest Stock News & Market Updates - StockTitan

Nov 20, 2024

Nov 20, 2024

Kura Oncology to partner with Kyowa Kirin for blood cancer therapy - Reuters

Nov 20, 2024

Nov 20, 2024

Kura Oncology Lands $330M Deal with Kyowa Kirin for Cancer Drug Ziftomenib | KURA Stock News - StockTitan

Nov 20, 2024

Nov 20, 2024

Kura Oncology, Inc. (NASDAQ:KURA) Q3 2024 Earnings Call Transcript - MSN

Nov 20, 2024

Nov 20, 2024

Kura Oncology (NASDAQ:KURA) Cut to Sell at StockNews.com - MarketBeat

Nov 20, 2024

Nov 19, 2024

Kura Oncology's (KURA) Market Outperform Rating Reaffirmed at JMP Securities - MarketBeat

Nov 19, 2024

Nov 18, 2024

First Week of KURA July 2025 Options Trading - Nasdaq

Nov 18, 2024

Nov 18, 2024

Kura Oncology stock gains spotlight amid Revuforj's FDA approval By Investing.com - Investing.com UK

Nov 18, 2024

Nov 16, 2024

Objective long/short (KURA) Report - Stock Traders Daily

Nov 16, 2024

Nov 15, 2024

Paradigm Biocapital Advisors LP Adjusts Stake in Kura Oncology I - GuruFocus.com

Nov 15, 2024

Nov 14, 2024

Kura Oncology (NASDAQ:KURA) Raised to “Hold” at StockNews.com - Defense World

Nov 14, 2024

Nov 13, 2024

Kura Oncology's SWOT analysis: ziftomenib drives stock potential amid AML market - Investing.com Australia

Nov 13, 2024

Nov 13, 2024

HC Wainwright Reiterates "Buy" Rating for Kura Oncology (NASDAQ:KURA) - MarketBeat

Nov 13, 2024

Nov 11, 2024

FY2026 EPS Estimate for Kura Oncology Lifted by Analyst - MarketBeat

Nov 11, 2024

Nov 10, 2024

HC Wainwright Reaffirms Buy Rating for Kura Oncology (NASDAQ:KURA) - Defense World

Nov 10, 2024

Nov 10, 2024

Brokerages Set Kura Oncology, Inc. (NASDAQ:KURA) Price Target at $28.83 - MarketBeat

Nov 10, 2024

Nov 08, 2024

Kura Oncology Inc (KURA) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Rising Expenses - Yahoo Finance

Nov 08, 2024

Nov 08, 2024

Kura Oncology (NASDAQ:KURA) Shares Gap DownHere's What Happened - MarketBeat

Nov 08, 2024

Nov 07, 2024

Kura Oncology: Q3 Earnings Snapshot - San Francisco Chronicle

Nov 07, 2024

Nov 07, 2024

Kura Oncology Reports Third Quarter 2024 Financial Results - The Manila Times

Nov 07, 2024

Nov 07, 2024

Kura Oncology, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 07, 2024